AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials
(Bloomberg) -- AbbVie Inc. shares fell the most in three years after two mid-stage trials of its drug to treat...
Should You Forget Palantir and Buy These 2 AI Stocks Instead?
Palantir's (NYSE: PLTR) stock hit a record high of $51.13 on Nov. 5. Its 223% year-to-date rally was driven by...
BlackRock Plows $2 Billion Into Momentum Stocks After Election
(Bloomberg) -- The world’s biggest asset manager is leaning into the stock market’s post-election rally after shying away from risk...
Stock market today: Dow, S&P 500 extend rally as bitcoin tops $82,000, Tesla surges
US stocks climbed on Monday led by a continuation of the 'Trump trade' in the roaring post-election rally rally as...
Nvidia Stock Called ‘Must-Own,’ ‘Once-In-A-Lifetime Opportunity’
Nvidia (NVDA) stock received price-target increases Monday from two Wall Street analysts who gushed about the chipmaker's opportunity in artificial intelligence.
Melius Research analyst Ben...